Promising HIV vaccine fails in test

Mark Feinberg, head of medical affairs in Merck's vaccine division, said it has no other candidates in development.

The company still must do a detailed review of the data but he said he thinks this approach is dead.

Other scientists disagreed.

"You can't say that the whole field of T cell vaccines has been dealt a death blow" by the Merck results, Fauci said.